/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

A

Antonis Fanouriakis

National and Kapodistrian University of Athens(GR)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

213

Papers

7.2K

Citations

31

h-index

73

i10-index

Antonis Fanouriakis is an academic researcher from National and Kapodistrian University of Athens. The author has contributed to research in topics: Systemic Lupus Erythematosus Research & Atherosclerosis and Cardiovascular Diseases & Monoclonal and Polyclonal Antibodies Research. The author has an h-index of 31, co-authored 182 publications.

ORCID: 0000-0003-2696-031X

Research Topics

Systemic Lupus Erythematosus Research Atherosclerosis and Cardiovascular Diseases Monoclonal and Polyclonal Antibodies Research Systemic Sclerosis and Related Diseases Rheumatoid Arthritis Research and Therapies

Papers by this author

works

EULAR recommendations for the management of systemic lupus erythematosus: 2023 update

2023 · Annals of the Rheumatic Diseases · 803 citations

https://doi.org/10.1136/ard-2023-224762

Antonis Fanouriakis Myrto Kostopoulou Jeanette Andersen Martin Aringer

2019 Update of the Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the management of lupus nephritis

2020 · Annals of the Rheumatic Diseases · 788 citations

https://doi.org/10.1136/annrheumdis-2020-216924

Antonis Fanouriakis Myrto Kostopoulou Kim Cheema Hans‐Joachim Anders

Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression

2024 · Annals of the Rheumatic Diseases · 27 citations

https://doi.org/10.1136/ard-2023-224919

Sofia Pitsigavdaki Myrto Nikoloudaki Panagiotis Garantziotis Ettore Silvagni

EULAR recommendations for the management of systemic lupus erythematosus with kidney involvement: 2025 update

2025 · Annals of the Rheumatic Diseases · 15 citations

https://doi.org/10.1016/j.ard.2025.09.007

Antonis Fanouriakis Myrto Kostopoulou Hans‐Joachim Anders Jeanette Andersen

Restoration of aberrant gene expression of monocytes in systemic lupus erythematosus via a combined transcriptome-reversal and network-based drug repurposing strategy

2023 · BMC Genomics · 9 citations

https://doi.org/10.1186/s12864-023-09275-8

Dimitrios Nikolakis Panagiotis Garantziotis George Sentis Antonis Fanouriakis

Transcriptome analysis to decipher the molecular underpinnings of response to treatment in systemic lupus erythematosus

2025 · RMD Open · 3 citations

https://doi.org/10.1136/rmdopen-2024-005050

Panagiotis Garantziotis Georgia-Savina Moysidou Noemin Kapsala Sofia Flouda

Research topics

topics

Systemic Lupus Erythematosus Research

Atherosclerosis and Cardiovascular Diseases

Monoclonal and Polyclonal Antibodies Research

Systemic Sclerosis and Related Diseases

Rheumatoid Arthritis Research and Therapies

Chat about Author

Papers

Chat

Click to start Chat